Work

All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

Year: 1997

Type: article

Study design: Case Report

Source: PubMed

DOI: 10.1182/blood.v90.2.535

Authors: J D Rowley, S Reshmi, O Sobulo, T Musvee, J Anastasi, S Raimondi, N R Schneider, J C Barredo, E S Cantu, B Schlegelberger, F Behm, N A Doggett, J Borrow, N Zeleznik-Le

Institution: University of Chicago Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: CLINICAL PHENOTYPE TARGETED ANTIFOLATE CHEMOTHERAPY, CHROMOSOME ABNORMALITIES AND HUMAN LEUKEMIA AND LYMPHOMA

OpenAlex ID: W2210090508

FWCI: 10.33

Cites: 23

Cited by: 213

Related to: 10